Hummel Sandra, Beyerlein Andreas, Tamura Roy, Uusitalo Ulla, Andrén Aronsson Carin, Yang Jimin, Riikonen Anne, Lernmark Åke, Rewers Marian J, Hagopian William A, She Jin-Xiong, Simell Olli G, Toppari Jorma, Ziegler Anette-G, Akolkar Beena, Krischer Jeffrey P, Virtanen Suvi M, Norris Jill M
Institute of Diabetes Research, Helmholtz Zentrum München, Munich, and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Forschergruppe Diabetes e.V., Neuherberg, Germany
Institute of Diabetes Research, Helmholtz Zentrum München, Munich, and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Forschergruppe Diabetes e.V., Neuherberg, Germany.
Diabetes Care. 2017 Mar;40(3):398-404. doi: 10.2337/dc16-1624. Epub 2017 Jan 17.
Studies on the introduction of infant formulas and its effect on the risk of islet autoimmunity and type 1 diabetes (T1D) have yielded inconsistent results. We investigated whether the introduction of formula based on hydrolyzed cow's milk as the first formula is associated with reduced islet autoimmunity risk in a large prospective cohort.
The Environmental Determinants of Diabetes in the Young (TEDDY) study prospectively monitors 8,676 children at increased genetic risk for T1D. Autoantibodies to insulin, GAD65, and IA2 were measured regularly to define islet autoimmunity. Information on formula feeding was collected by questionnaires at 3 months of age.
In survival analyses, after adjustment for family history with T1D, HLA genotype, sex, country, delivery mode, breast-feeding ≥3 months, and seasonality of birth, we observed no significant association with islet autoimmunity in infants who received extensively hydrolyzed compared with nonhydrolyzed cow's milk-based formula as the first formula during the first 3 months (adjusted hazard ratio 1.38 [95% CI 0.95; 2.01]), and a significantly increased risk for extensively hydrolyzed formula introduced during the first 7 days (adjusted hazard ratio 1.57 [1.04; 2.38]). Using a partially hydrolyzed or other formula as the first formula, or no formula, was not associated with islet autoimmunity risk.
These results add to the existing evidence that islet autoimmunity risk is not reduced, and may be increased, by using hydrolyzed compared with nonhydrolyzed cow's milk-based infant formula as the first formula in infants at increased genetic risk for T1D.
关于婴儿配方奶粉的引入及其对胰岛自身免疫风险和1型糖尿病(T1D)影响的研究结果并不一致。我们在一个大型前瞻性队列中调查了以水解牛奶为基础的配方奶粉作为首种配方奶粉的引入是否与胰岛自身免疫风险降低相关。
青少年糖尿病环境决定因素(TEDDY)研究前瞻性监测了8676名T1D遗传风险增加的儿童。定期检测胰岛素、谷氨酸脱羧酶65(GAD65)和胰岛抗原2(IA2)的自身抗体以确定胰岛自身免疫情况。通过问卷调查收集3个月大时的配方奶喂养信息。
在生存分析中,在对T1D家族史、人类白细胞抗原(HLA)基因型、性别、国家、分娩方式、母乳喂养≥3个月和出生季节进行调整后,我们观察到,在前3个月内,与未水解的牛奶配方奶粉相比,接受深度水解牛奶配方奶粉作为首种配方奶粉的婴儿与胰岛自身免疫无显著关联(调整后的风险比为1.38 [95%置信区间0.95;2.01]),而在出生后第1周内引入深度水解配方奶粉的风险显著增加(调整后的风险比为1.57 [1.04;2.38])。使用部分水解配方奶粉或其他配方奶粉作为首种配方奶粉,或不使用配方奶粉,均与胰岛自身免疫风险无关。
这些结果进一步证明,对于T1D遗传风险增加的婴儿,与未水解的牛奶配方奶粉相比,使用水解牛奶配方奶粉作为首种配方奶粉并不能降低胰岛自身免疫风险,甚至可能增加风险。